Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevalence of Anxiety and Depression in Adolescents With PCOS
NCT07127458Completed
- Sponsor
- Ege University
- Start
- Aug 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ethinyl estradiol and drospirenone in polycystic ovary syndrome (PCOS), major depressive disorder (MDD) and anxiety disorder, sponsored by Ege University. Primary endpoint: Beck Depression Inventory at 6 months. Started Aug 2025; status: completed.
02
Drugs
ethinyl estradioldrospirenone
03
Conditions
polycystic ovary syndrome (PCOS)major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT07127458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07127458.